The forecasts are closely monitored by coastal communities and...
Category:
International News
Latest
Magnitude 4.7 earthquake hits New York City region, USGS says
The quake's epicenter was near Whitehouse Station, New Jersey, the...
Scientists warn of lethal bird flu pandemic, says could be ‘100 times worse’ than COVID
Around 52 per cent of humans who have contracted H5N1 since 2003...
Aviation bodies seek airport slots waiver for much of 2021
The draft proposal to be issued jointly by IATA, airports body ACI and slot coordinators, calls on regulators to extend the current waiver of rules requiring airlines to use 80% of their take-off and landing windows or else cede some to rivals.
CEO says AstraZeneca likely to run new global Covid vaccine trial: Report
In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses.
The biggest threat to Covid-19 vaccination could be fake news and misinformation
“The coronavirus disease is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected,” the WHO said.
“At the same time, the technology we rely on to keep connected and informed is enabling and amplifying an infodemic that continues to undermine the global response and jeopardises measures to control the pandemic.”
Covid vaccine rush in China raises fears of booming black market
As developers from AstraZeneca Plc to Pfizer Inc. near the finish line for their coronavirus vaccines, nations are preparing for the challenge of rolling them out, with inevitable supply shortages fueling concerns about inequitable distribution and even the emergence of illegal markets. One place where vaccine delivery is already being road-tested is China, which has allowed local developers’ shots for emergency use since mid-year.
Europe’s drugs watchdog expects first marketing application for coronavirus vaccine in days
The European Medicines Agency (EMA) did not name the company it expects to file the application, but Pfizer Inc and BioNTEch are the most advanced in the regulatory process among the three companies that have published late-stage trial data for their vaccines.
World agonises over new COVID curbs as infections approach 60 million
an approved vaccine is unlikely to be widely available for months while scientists insist on the continued need for vigilance and politicians consider curbs for Christmas amid a second wave of the pandemic.
Fintechs seen eating into market share of established insurers, EU says
Insurers and reinsurers such as AXA and Munich Re have been investing in so-called insurtech companies, considered a faster way for them to adapt to technology changes.
Stephen Catlin, chairman and chief executive of Convex, a newcomer to the insurance, told the event that fintech firms faced a learning curve to compete with established players.
AIA pares coal investments, faces environment group scrutiny
The Hong Kong-based insurer said it decided to end all direct equity investments in coal mining and coal-fired power producers earlier this year, according to an emailed statement Tuesday.
SCOR CEO sees double-digit reinsurance rate rises
“All conditions are met today for rate increases,” he said.
Kessler said the cost of the pandemic was mostly already accounted for in the reinsurer’s previously published loss estimates. If there was a third wave the company would revise its assumptions, he added.
Global coronavirus cases surpass 60 million infections
An analysis of the Reuters data showed the rate of new infections picking up globally. It took just 17 days to go from 50 million cases to 60 million, compared with the 21 days it took to go from 40 million to 50 million. Around 580,000 cases have been reported each day over the past week and around half of all cases since the start of the pandemic were reported over the past 70 days.
In Europe, 1 million new cases were recorded over just five days, for a total of more than 16 million cases, including 365,000 deaths.